Last reviewed · How we verify

NCT04042571: COMOVA

Permanent Cerebral Oxymetry Monitoring for Early Diagnosis and Treatment of Delayed Vasospasm After Subarachnoid Hemorrhage

Completed NA Last updated 24 July 2025
What this trial tests

NA trial testing Cerebral oxymetry monitoring (NIRS) in Subarachnoid Hemorrhage in 50 participants. Completed in 30 December 2022.

Timeline
1 October 2019
Primary endpoint
24 December 2022
30 December 2022

Quick facts

Lead sponsorUniversity Hospital, Bordeaux
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment50
Start date1 October 2019
Primary completion24 December 2022
Estimated completion30 December 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Subarachnoid Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Transcranial Doppler ultrasound (TCD) monitoring and CT-scanner perfusion are useful but imperfect tools to identify vasospasm and allow intervention to avoid infarction. Permanent monitoring of cerebral tissue oximetry (rSO2) by NIRS, a noninvasive method could allow better vasospasm detection. This study will evaluate diagnostic accuracy of cerebral oxymetry (NIRS) -by rSO2 measurement - in order to detect vasospasm in patient with severe subarachnoid hemorrhage compare to standard monitoring tools.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Vasospasm-Related Death after Aneurysmal Subarachnoid Hemorrhage: A Retrospective Case-Control Study.
    Khanafer A, Bhogal P, Hellstern V, Harmening C, et al · · 2022 · cited 10× · PMID 36012881 · DOI 10.3390/jcm11164642

Verify or expand the search:

Other recruiting trials for Subarachnoid Hemorrhage

Currently open trials in the same condition.

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04042571.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing